Eventide Asset Management - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 122 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q1 2023. The put-call ratio across all filers is 1.34 and the average weighting 0.4%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q3 2023$10,696,700
-31.3%
490,0000.0%0.19%
-27.0%
Q2 2023$15,577,100
+104.7%
490,000
+57.1%
0.26%
+87.9%
Q1 2023$7,609,680312,0000.14%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q1 2023
NameSharesValueWeighting ↓
BAIN CAPITAL INVESTORS LLC 60,199,729$1,314,160,08442.08%
Perceptive Advisors 10,088,385$220,229,4457.35%
Finepoint Capital LP 563,345$12,297,8216.12%
Affinity Asset Advisors, LLC 685,061$14,954,8824.21%
Paradigm Biocapital Advisors LP 2,532,972$55,294,7793.75%
Logos Global Management LP 700,000$15,281,0002.04%
Artal Group S.A. 1,638,858$35,7761.53%
Rock Springs Capital Management LP 2,529,116$55,210,6021.48%
GREAT POINT PARTNERS LLC 215,000$4,693,4500.86%
Frazier Life Sciences Management, L.P. 393,000$8,579,1900.57%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders